AI-Powered Diagnostic Innovations for Early Detection, Made Simple
Medzak Healthcare delivers medical-grade ocular and metabolomic diagnostics for hospitals, labs, and outreach camps. Patented, clinically validated deeptech technologies built for early detection — without the high cost of traditional equipment.
- Estd. 2018
- Patented optical technology
- Clinically validated AI
Latest from LinkedIn
Supporters and Funders
About Us
Founded in 2018, Medzak Healthcare started with a mission to close the gap between the world’s growing burden of eye and metabolic disease and the diagnostic tools available to detect it early — before it becomes expensive, invasive, or irreversible.
Our Mission
To build portable, affordable, AI-powered diagnostic devices for ocular and metabolic health, that bring hospital-grade screening to OPDs, outreach camps, and underserved communities.
Our Vision
To see a world where no patient loses their sight, or their health, to a disease that could have been caught early.
Our Solution
Across four products — Meibo-X for ocular diagnostics, Metabo-X for metabolic risk prediction, VuOpt for close-range optical imaging and Angel-X for angle-closure glaucoma detection — we combine imaging, AI, and clinical validation into devices that are fast, low-cost, and built for real-world care.
Innovating for Disease Prevention